Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Bevacizumab & Colorectal Cancer (CRC), Bevacizumab is approved by both the FDA and EMA for use in Colorectal Cancer (CRC)
Bevacizumab has shown effectiveness in metastatic Colorectal Cancer (CRC). There is an urgent need to enhance the understanding of its mechanism of action and how Bevacizumab resistance develops. Additionally, identifying predictive markers for Bevacizumab's efficacy and toxicity is necessary (2).
The Observational Cohort BRiTE study showed that continuing to [inhibit vascular endothelial growth factor](brain://AO-6056h-ECilY-7kRp0ZQ/Vascu…